Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

OptumRx buys PBM Catamaran for $13bn

Executive Summary

UnitedHealth Group Co.'s OptumRx Inc. acquired Catamaran Corp., a public pharmacy benefits manager, for $13bn in cash, or $61.50 per share (a 25% premium), creating one of the leading PBMs in the US alongside Express Scripts and CVS. The combined OptumRx/Catamaran will be led by Catamaran's existing chairman and CEO Mark Thierer.
Deal Industry
  • Pharmaceuticals
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies